| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Activation of immune responses in patients with relapsed-metastatic head and neck cancer (CONFRONT phase I-II trial): Multimodality immunotherapy with avelumab, short-course radiotherapy, and cyclophosphamide
|
Merlano, Marco C.
|
|
2018
|
12 |
C |
p. 47-52
|
article
|
| 2 |
A neuropathic pain component as a predictor of improvement in pain interference after radiotherapy for painful tumors: A secondary analysis of a prospective observational study
|
Saito, Tetsuo
|
|
2018
|
12 |
C |
p. 34-39
|
article
|
| 3 |
A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?
|
Ng, Sweet Ping
|
|
2018
|
12 |
C |
p. 40-46
|
article
|
| 4 |
Four different treatment strategies in aggressive fibromatosis: A systematic review
|
Seinen, Jojanneke M.
|
|
2018
|
12 |
C |
p. 1-7
|
article
|
| 5 |
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic
|
Patrikidou, Anna
|
|
2018
|
12 |
C |
p. 28-33
|
article
|
| 6 |
Leukocytosis, prognosis biomarker in locally advanced head and neck cancer patients after chemoradiotherapy
|
Schernberg, Antoine
|
|
2018
|
12 |
C |
p. 8-15
|
article
|
| 7 |
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours
|
Dillon, M.T.
|
|
2018
|
12 |
C |
p. 16-20
|
article
|
| 8 |
Verification of HE-based CTV in laryngeal and hypopharyngeal cancer using pan-cytokeratin
|
Ligtenberg, Hans
|
|
2018
|
12 |
C |
p. 21-27
|
article
|
Journal description